Bookmark and Share
CHEMBL2171479 (CID 50897765) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(3)
 
 
Inactive(2)
 
 
Inconclusive(1)
 
 
Unspecified(2)
 
 
BioAssay Types:
Literature(4)
 
 
 
 
Confirmatory(4)
 
 
 
BioActivity Types:
IC50(2)
 
 
EC50(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 8    Data Row: 8   Total Pages: 1   
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID109967233]
CC50 8.26An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) using synethesized compounds (6) [AID504509, Type: confirmatory]
View
2
[SID163331462]
CC50 9.7Cytotoxicity against human Hep2 cells by Cell Titer-Glo assay [AID701508, Type: Literature]
View
3
[SID109967233]
Average CC50 10.6An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) using synethesized compounds (8) [AID504818, Type: confirmatory]
View
4
[SID163331462]
EC50 50Antiviral activity against Respiratory syncytial virus Long infected in human Hep2 cells assessed as reduction in virus-induced cytopathogenicity by Cell Titer-Glo assay [AID701507, Type: Literature]
View
5
[SID163331462]
Selectivity index, ratio of CC50 for human Hep2 cells to EC50 for Respiratory syncytial virus Long infected in human Hep2 cells [AID701509, Type: Literature]
View
6
[SID109967233]
IC50 50A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) using synthesized compounds (6) [AID504526, Type: confirmatory]
View
7
[SID109967233]
Average IC50 A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) using synthesized compounds (8) [AID504820, Type: confirmatory]
View
8
[SID163331462]
Antiviral activity against Respiratory syncytial virus Long infected in human Hep2 cells assessed as log reduction in virus titer at 25 uM by virus plaque reduction assay [AID701510, Type: Literature]
View